Gerresheimer reports new Goldman stake structure, MDAX shares trade steadily on Xetra

Gerresheimer updates the market on a revised voting rights structure linked to Goldman Sachs, as disclosed via EQS under Germany's transparency rules. The MDAX-listed packaging specialist remains on the radar of international investors.

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-22, 20:43.

Gerresheimer (DE000A0LD6E6) has reported an updated voting rights structure involving Goldman Sachs, following a major holdings notification disseminated via EQS under section 40 of the German Securities Trading Act. The MDAX company, whose shares trade on Xetra, remains under close observation from institutional investors according to the latest disclosure. EQS voting rights announcement

What the new notification shows

The latest voting rights notification names The Goldman Sachs Group, Inc. as the party subject to the reporting obligation, with the threshold event dated 15 June 2026 and formally published on 22 June 2026 via EQS News. dpa-AFX summary of the EQS filing The filing specifies that the trigger was a combination of transactions in shares with voting rights and related financial instruments, as defined in sections 33 and 38 of the German Securities Trading Act.

According to the notification, Goldman Sachs and its asset management entities now report 8.79 percent of Gerresheimer voting rights attached to shares and 11.18 percent via instruments, resulting in a combined position of 19.97 percent of total voting rights in the company. Detailed EQS data as reproduced in regulatory feeds Within this structure, approximately 3,034,357 voting rights are attributed indirectly to shares, while a further 3,276,636 voting rights stem from instruments such as rights to recall, rights of use, call warrants and options.

Goldman and asset management chain

The notification sets out a full chain of controlled undertakings starting with The Goldman Sachs Group, Inc. and extending through several holding and asset management entities in the United States, the Netherlands and the United Kingdom, ending with operational units such as Goldman Sachs Asset Management B.V. and Goldman Sachs International. EQS voting rights announcement Within this chain, Goldman Sachs Asset Management B.V. is listed with 8.75 percent of voting rights, while Goldman Sachs International appears with 7.94 percent of voting rights through instruments in the Gerresheimer shares.

The filing clarifies that the notification is triggered by acquisition and disposal both of shares with voting rights and of instruments, while a change in the breakdown of voting rights is not cited as a separate reason. The total number of voting rights in Gerresheimer is reported at 34,540,000, providing the basis for calculating the percentage figures disclosed in the filing. Investing.com reproduction of the EQS notice

The business behind the stock

Gerresheimer builds its business around specialty packaging and delivery systems for the healthcare and pharmaceutical industries, with glass and plastic solutions spanning primary packaging, drug delivery devices and diagnostics components. A central product line is prefillable syringes, where Gerresheimer supplies high-quality glass syringes and polymer variants used for injectable biologics and vaccines by pharmaceutical companies worldwide.

Where the stock trades today

The Gerresheimer shares (DE000A0LD6E6) trade on Xetra at 110.00 euros as of 2026-06-22, 14:41 CET.

Gerresheimer at a glance

• Company: Gerresheimer AG
• ISIN: DE000A0LD6E6
• WKN: A0LD6E
• Ticker: GXI
• Trading venue: Xetra
• Price (as of 2026-06-22, 14:41): 110.00 EUR
• Market cap: 3,450,000,000 EUR (as of 2026-06-22)
• Sector / industry: Health Care - Pharmaceuticals Packaging & Medical Supplies
• Index membership: MDAX
• Next earnings date: 2026-07-11

This article is for informational purposes only and does not constitute investment advice, an offer or a solicitation to buy or sell any financial instruments. Past performance is not indicative of future results. Readers should conduct their own research or consult a qualified advisor before making investment decisions.